Ability of non-fasting and fasting triglycerides to predict coronary artery disease in lupus patients.

scientific article published on 24 November 2011

Ability of non-fasting and fasting triglycerides to predict coronary artery disease in lupus patients. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/RHEUMATOLOGY/KER339
P698PubMed publication ID22120460
P5875ResearchGate publication ID51837202

P50authorDafna D. GladmanQ37605821
P2093author name stringMurray B Urowitz
Zahi Touma
Dominique Ibañez
P2860cites workFasting lipids and anticardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosusQ28319260
The 1982 revised criteria for the classification of systemic lupus erythematosusQ29547225
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosusQ29614922
Premature atherosclerosis in systemic lupus erythematosusQ33893354
Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosusQ34098573
The metabolic syndrome: prevalence, CHD risk, and treatmentQ36408039
Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL.Q37209371
Risk factors for development of coronary artery disease in women with systemic lupus erythematosusQ37615743
Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosusQ38454380
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in womenQ40192779
Difference between fasting and nonfasting triglyceridemia; the influence of waist circumferenceQ43281114
The bimodal mortality pattern of systemic lupus erythematosusQ43703475
Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.Q44441787
Nonfasting triglycerides and risk of ischemic stroke in the general populationQ44734713
Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk predictionQ46291367
Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies.Q51577475
Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective study.Q51680170
SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluation.Q51733116
SLEDAI-2K for a 30-day window.Q51799721
Triglycerides and the Risk of Coronary Heart DiseaseQ57267183
P433issue3
P921main subjectcoronary artery diseaseQ844935
triglycerideQ186319
P304page(s)528-534
P577publication date2011-11-24
P1433published inRheumatologyQ7320492
P1476titleAbility of non-fasting and fasting triglycerides to predict coronary artery disease in lupus patients.
P478volume51

Reverse relations

cites work (P2860)
Q35525108Atherosclerosis in systemic lupus erythematosus
Q37330468Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review.
Q34081242Cardiovascular involvement in autoimmune diseases
Q37673404Concentrated fish oil (Lovaza(R)) extends lifespan and attenuates kidney disease in lupus-prone short-lived (NZBxNZW)F1 mice
Q51305109Deviant early pregnancy maternal triglyceride levels and increased risk of congenital anomalies: a prospective community-based cohort study.
Q38230699Pathogenesis and treatment of atherosclerosis in lupus
Q39283399The evolving concept of SLE comorbidities.

Search more.